There is no cure for Fabry disease. Recombinant alpha-galactosidase A (alpha-Gal A), the enzyme that is deficient in patients with Fabry disease, and migalastat hydrochloride, an oral pharmacologic chaperone that facilitates trafficking of alpha-Gal A to lysosomes, are therapeutic options for eligible individuals.
How long is the average lifespan of a person with Fabry disease?
Published data from the Fabry registry indicates that male Fabry disease patients live an average of about 58 years, compared to about 75 years for men in the general population in the U.S. For women with Fabry disease, the average life expectancy is around 75 years compared to 80 years for women in the U.S. general …
What is Febreze disease?
Fabry disease is a rare genetic disease with a deficiency of an enzyme called alpha-galactosidase A. The disease affects many parts of the body including the skin, eyes, gastrointestinal system, kidney, heart, brain, and nervous system. Symptoms of Fabry disease include: Episodes of pain and burning sensations.
What is Gb3 in Fabry disease?
Fabry disease (FD) is an X-linked lysosomal storage disorder that results from a deficiency in the activity of α-galactosidase A (α-Gal A). 1. The α-Gal A deficiency causes systemic lysosomal accumulation of glycolipids, predominantly globotriaosylceramide (Gb3), in the vascular endothelium and other tissues.
How does Fabry disease affect the skin?
It is also known as Anderson–Fabry disease and angiokeratoma corporis diffusum. Fabry disease causes clusters of angiokeratomas (small, dark red spots on the skin) and many systemic symptoms due to the deposition of globotriaosylceramide (Gb3) in multiple organs.
What are the treatment options for Fabry disease?
Treatment with enzyme replacement may, in the future, be able to prevent the development of kidney failure in many people with Fabry disease.
What is fabfabry disease and is it serious?
Fabry disease is a serious condition. The disease can have variable effects, but often affected people develop complete kidney failure in their 20’s, and die of heart disease or stroke in their 30’s or 40’s. However, the new treatment with enzyme replacement (see below) may dramatically improve the outcome of this disease.
What did Dr Fabry do?
Dr Johann Fabry continued to work in this specialised area, and the disease was subsequently named after him. Much more work was conducted from that time to this, which has led toward developing a treatment for Fabry disease.
Does Fabry disease affect a kidney transplant?
A kidney transplant does not get affected by Fabry disease because it contains small amounts of the enzyme alpha-galactosidase from the donor, which protects the kidney (but unfortunately cannot help Fabry disease in the rest of the body).
